
### [MONDO:0002334](http://purl.obolibrary.org/obo/MONDO_0002334)
**Label:** hematologic cancer

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0005029](http://purl.obolibrary.org/obo/MONDO_0005029) (essential thrombocythemia), [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0018908](http://purl.obolibrary.org/obo/MONDO_0018908) (non-Hodgkin lymphoma), [MONDO:0015759](http://purl.obolibrary.org/obo/MONDO_0015759) (b-cell non-Hodgkin lymphoma), [MONDO:0005062](http://purl.obolibrary.org/obo/MONDO_0005062) (lymphoma), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large B-cell lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0015758](http://purl.obolibrary.org/obo/MONDO_0015758) (primary cutaneous T-cell lymphoma), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (bilineal acute myeloid leukemia), [MONDO:0017858](http://purl.obolibrary.org/obo/MONDO_0017858) (acute erythroid leukemia), [MONDO:0018897](http://purl.obolibrary.org/obo/MONDO_0018897) (primary cutaneous CD30+ T-cell lymphoproliferative disease), [MONDO:0015820](http://purl.obolibrary.org/obo/MONDO_0015820) (primary cutaneous b-cell lymphoma), [MONDO:0018898](http://purl.obolibrary.org/obo/MONDO_0018898) (primary cutaneous lymphoma), [MONDO:0020331](http://purl.obolibrary.org/obo/MONDO_0020331) (indolent systemic mastocytosis), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0009348](http://purl.obolibrary.org/obo/MONDO_0009348) (classic Hodgkin lymphoma), [MONDO:0019460](http://purl.obolibrary.org/obo/MONDO_0019460) (acute leukemia of ambiguous lineage), [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0017604](http://purl.obolibrary.org/obo/MONDO_0017604) (marginal zone lymphoma), [MONDO:0015667](http://purl.obolibrary.org/obo/MONDO_0015667) (unclassified acute myeloid leukemia), [MONDO:0015821](http://purl.obolibrary.org/obo/MONDO_0015821) (mycosis fungoides and variants), [MONDO:0017207](http://purl.obolibrary.org/obo/MONDO_0017207) (primary organ-specific lymphoma), [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0009692](http://purl.obolibrary.org/obo/MONDO_0009692) (primary myelofibrosis), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0019457](http://purl.obolibrary.org/obo/MONDO_0019457) (Therapy related acute myeloid leukemia and myelodysplastic syndrome), [MONDO:0017595](http://purl.obolibrary.org/obo/MONDO_0017595) (aggressive b-cell non-Hodgkin lymphoma), [MONDO:0019454](http://purl.obolibrary.org/obo/MONDO_0019454) (refractory anemia with excess blasts), [MONDO:0019452](http://purl.obolibrary.org/obo/MONDO_0019452) (chronic myeloproliferative disease, unclassifiable), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0017594](http://purl.obolibrary.org/obo/MONDO_0017594) (indolent b-cell non-Hodgkin lymphoma), [MONDO:0020325](http://purl.obolibrary.org/obo/MONDO_0020325) (anaplastic large cell lymphoma), [MONDO:0004952](http://purl.obolibrary.org/obo/MONDO_0004952) (Hodgkins lymphoma), [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0015817](http://purl.obolibrary.org/obo/MONDO_0015817) (aggressive primary cutaneous T-cell lymphoma), [MONDO:0015816](http://purl.obolibrary.org/obo/MONDO_0015816) (indolent primary cutaneous T-cell lymphoma), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0018874](http://purl.obolibrary.org/obo/MONDO_0018874) (acute myeloid leukemia), [MONDO:0018872](http://purl.obolibrary.org/obo/MONDO_0018872) (acute megakaryoblastic leukemia), [MONDO:0015760](http://purl.obolibrary.org/obo/MONDO_0015760) (T-cell non-Hodgkin lymphoma), [MONDO:0020078](http://purl.obolibrary.org/obo/MONDO_0020078) (acute myeloid leukemia with recurrent genetic anomaly), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), [MONDO:0020311](http://purl.obolibrary.org/obo/MONDO_0020311) (chronic myelomonocytic leukemia), [MONDO:0020312](http://purl.obolibrary.org/obo/MONDO_0020312) (atypical chronic myeloid leukemia), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0005615](http://purl.obolibrary.org/obo/MONDO_0005615) (plasmacytoma), [MONDO:0004967](http://purl.obolibrary.org/obo/MONDO_0004967) (acute lymphoblastic leukemia (disease)), [MONDO:0020076](http://purl.obolibrary.org/obo/MONDO_0020076) (myeloproliferative neoplasm), [MONDO:0013667](http://purl.obolibrary.org/obo/MONDO_0013667) (myelodysplastic syndrome), 

**Corr. equiv. classes:** [Orphanet:86839](http://www.orpha.net/ORDO/Orphanet_86839), [Orphanet:178548](http://www.orpha.net/ORDO/Orphanet_178548), [Orphanet:300846](http://www.orpha.net/ORDO/Orphanet_300846), [Orphanet:33226](http://www.orpha.net/ORDO/Orphanet_33226), [OMIM:151380](http://purl.obolibrary.org/obo/OMIM_151380), [Orphanet:300842](http://www.orpha.net/ORDO/Orphanet_300842), [OMIM:153600](http://purl.obolibrary.org/obo/OMIM_153600), [Orphanet:86830](http://www.orpha.net/ORDO/Orphanet_86830), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519), [Orphanet:171901](http://www.orpha.net/ORDO/Orphanet_171901), [Orphanet:518](http://www.orpha.net/ORDO/Orphanet_518), [Orphanet:514](http://www.orpha.net/ORDO/Orphanet_514), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [Orphanet:318](http://www.orpha.net/ORDO/Orphanet_318), [Orphanet:71493](http://www.orpha.net/ORDO/Orphanet_71493), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513), [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [Orphanet:178557](http://www.orpha.net/ORDO/Orphanet_178557), [Orphanet:98293](http://www.orpha.net/ORDO/Orphanet_98293), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [Orphanet:178551](http://www.orpha.net/ORDO/Orphanet_178551), [Orphanet:391](http://www.orpha.net/ORDO/Orphanet_391), [Orphanet:178554](http://www.orpha.net/ORDO/Orphanet_178554), [OMIM:614286](http://purl.obolibrary.org/obo/OMIM_614286), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [OMIM:254450](http://purl.obolibrary.org/obo/OMIM_254450), [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [Orphanet:171915](http://www.orpha.net/ORDO/Orphanet_171915), [Orphanet:98848](http://www.orpha.net/ORDO/Orphanet_98848), [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [Orphanet:547](http://www.orpha.net/ORDO/Orphanet_547), [Orphanet:824](http://www.orpha.net/ORDO/Orphanet_824), [Orphanet:223735](http://www.orpha.net/ORDO/Orphanet_223735), [Orphanet:544](http://www.orpha.net/ORDO/Orphanet_544), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:98841](http://www.orpha.net/ORDO/Orphanet_98841), [Orphanet:171918](http://www.orpha.net/ORDO/Orphanet_171918), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), [OMIM:236000](http://purl.obolibrary.org/obo/OMIM_236000), [Orphanet:542](http://www.orpha.net/ORDO/Orphanet_542), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [Orphanet:541](http://www.orpha.net/ORDO/Orphanet_541), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [Orphanet:86855](http://www.orpha.net/ORDO/Orphanet_86855), [Orphanet:178566](http://www.orpha.net/ORDO/Orphanet_178566), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:178563](http://www.orpha.net/ORDO/Orphanet_178563), [Orphanet:86851](http://www.orpha.net/ORDO/Orphanet_86851), [Orphanet:98836](http://www.orpha.net/ORDO/Orphanet_98836), [Orphanet:167714](http://www.orpha.net/ORDO/Orphanet_167714), [Orphanet:98274](http://www.orpha.net/ORDO/Orphanet_98274), [Orphanet:98277](http://www.orpha.net/ORDO/Orphanet_98277), [Orphanet:86846](http://www.orpha.net/ORDO/Orphanet_86846), [Orphanet:300912](http://www.orpha.net/ORDO/Orphanet_300912), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [Orphanet:279911](http://www.orpha.net/ORDO/Orphanet_279911), [Orphanet:98823](http://www.orpha.net/ORDO/Orphanet_98823), [Orphanet:98824](http://www.orpha.net/ORDO/Orphanet_98824), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), 

**Class expressions from DL-Learner:**

- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face))) 49.84%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head))) 49.84%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck))) 49.84%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia))) 49.38%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes))) 49.38%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract))) 49.21%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000078](http://purl.obolibrary.org/obo/HP_0000078) (Abnormality of the genital system))) 49.16%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0001000](http://purl.obolibrary.org/obo/HP_0001000) (Abnormality of skin pigmentation))) 48.70%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0003549](http://purl.obolibrary.org/obo/HP_0003549) (Abnormality of connective tissue))) 48.25%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system))) 48.05%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology))) 47.83%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion))) 47.00%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000079](http://purl.obolibrary.org/obo/HP_0000079) (Abnormality of the urinary system))) 47.00%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system))) 46.93%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology))) 46.50%


